Raising Funding For Blood Cancer &
Who We Are
The mission of the Meredith A. Cowden Foundation is to increase the number of leukemia survivors, to raise awareness of the blood cancers and help people living with the treatment of them, to improve the post-transplant quality of life for bone marrow transplant recipients, and to support the Leukemia & Lymphoma Society.
The Meredith A. Cowden Foundation is a 501(c)(3) non-profit that was formed in 2007. We are headquartered in Akron, Ohio
Why We Are Important
Every year approximately 30,000 patients undergo a bone marrow or stem cell transplant. Approximately 50% survive. There are currently 100,000 survivors in the US. Of the remaining survivors, approximately 75% are diagnosed with Graft vs. Host Disease (GvHD).
GvHD is a complication of the transplant. It can be an acute or chronic condition that occurs when the new immune system (graft) created by the bone marrow transplant attacks the organs and tissues of the patient (host.) Sadly, it can be fatal if not controlled and currently there is no cure. It affects both adults and children.
The treatment for GvHD is a series of immunosuppressant drugs, which in and of themselves have significant side effects and do long-term damage to the patient’s body. For example, a very common side effect is cataracts (regardless of a patient’s age).
What We Do
Every year since 2010, the Foundation has sponsored the National GvHD Symposium. The Symposium Planning Committee, consisting of physicians from the Cleveland Clinic Taussig Cancer Institute, UH Seidman Cancer Center, Johns Hopkins Medical Center, Moffitt Cancer Center, University of Pittsburgh Medical Center and the National Institutes of Health recruits research doctors to make presentations to clinicians to educate them about the latest research and procedures to treat chronic GvHD. In addition, we invite speakers to make presentations to patients, their caregivers and families. These presentations are to provide advice and help in coping with the trials and tribulations of living with GvHD. Please see the brochure from our 2017 seminar, which was held in Columbus, Ohio with over 200 people attending, and our Save the Date card for this year’s symposium which is being held in Cleveland, Ohio on April 26, 2019.
In addition, we provide grants to organizations such as the Leukemia & Lymphoma Society, the National Bone Marrow Transplant LINK (nbmtLINK), the Blood and Marrow Transplant InfoNet (BMTInfoNet) and others. Prior to 2010, we provided funding for research to several major research hospitals.
How We Fund Our Activities
Our main fundraiser is a gourmet wine dinner, which we have named “Six Courses for a Cure.” This event has been very successful and well received by our supporters. The 2018 fundraiser netted more than $35,000.
Learn More About Us
Help us connect people to the help they deserve. Your support is more than a donation, it is an investment in the lives of children and adults struggling with GvHD. Fund groundbreaking research to discover a cure for this devasting disease. Every dollar matters.
What Is GvHD?
During allogeneic stem cell transplantation, donor cells (“the graft”) may also attack the patient’s healthy tissues and organs (“the host”), which can impair the tissue or organ’s function or may cause it to fail altogether. This condition is called “graft-versus-host disease” or GVHD.
The National GvHD Health Symposium
The Meredith A. Cowden Foundation volunteers are at the heart of everything we do. They fundraise, they advocate for life-saving change, and they’re committed to helping us achieve our mission. We’d love for you to join them. For more information on how to volunteer, contact us at Info@Cowdenfoundation.org
The GvHD Symposium
Six Courses For A Cure
Six Courses for a Cure is the result of the creative genius of Executive Chef Roger Thomas, Beverly Hills, CA. and Pete Olsen, owner of The Tasting Room, Wadsworth, Ohio.
Cowden Craft Series
Our most recent blog entries, including news and updates to our events and partnerships
The 2020 Graft vs Host Disease National Symposium will be held in Cleveland on Oct 2nd, 2020. Watch for more information.
KEYNOTE SPEAKER: Joseph H. Antin, MD Dana Farber Cancer Insitute Dr. Antin received his MD from Cornell University in 1978, and postgraduate training in hematology and medical oncology at DFCI and Brigham and Women's Hospital. He subsequently served as director of the...
Wednesday, September 26, 2018, at Noon EST (1.30 hours) Note: start time will vary by time zone We invite you to participate in a FREE webinar that will be sure to help you and your loved ones better understand the complexities of cGVHD as related to cancer treatment...
Let’s Get Started
Give the gift of hope